News
1d
Zacks Investment Research on MSNBayer Gets FDA Nod for Label Expansion of Kerendia in Heart FailureBayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The ...
Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific ...
The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...
The FDA intends the proposed rule “to provide consistent formatting of new animal drug labeling” and cites several issues as the impetus of these proposed rules—chief among them that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results